Will DocuSign report FY2027 stock-based compensation below 18% of revenue?

Historical base rate: SBC as % of revenue has declined 1.2-1.6pp per year for two consecutive years (22.1% → 20.5% → 19.3%). The required improvement to reach 18.0% is 1.3pp — squarely within the historical range. If the trend continues at its average pace, DocuSign would land at approximately 17.9-18.1%, right at the boundary. The mechanical analysis is the key: FY2026 SBC was $622.3M, and the threshold is $628M. SBC would need to grow at most 0.9%, versus the 2-year average of ~1.1%. This means the base rate extrapolation actually slightly favors NO (SBC at ~$629M, 18.0%). However, the trend is accelerating toward fewer equity grants (PSU shift, lower-cost locations), suggesting the recent 2% growth rate in FY2026 may be the high-water mark. Base rate assessment: 58% YES, acknowledging the trajectory lands very close to the boundary.

Pure base rate extrapolation: FY2025→FY2026 SBC grew 2.0% ($610M→$622M). If FY2027 SBC grows at the same 2.0% rate, SBC would be ~$635M. Revenue at $3,490M midpoint would yield SBC/revenue of 18.2% — resolving NO. For YES, SBC growth needs to decelerate to <1%. The prior year decelerated from ~0.2% growth to 2.0% growth — the direction was actually toward more SBC growth, not less. The two-year trend in SBC growth rate doesn't clearly favor continued deceleration. However, the FY2024→FY2025 near-flat period suggests SBC can be held flat when management prioritizes it. This is a genuine coin flip with slight edge to YES based on structural levers cited by CFO. Base rate: 52%.

The base rate framing is that SBC % of revenue has declined every year for 3 years running (22.1% → 20.5% → 19.3%). The pace of 1.2-1.6pp/year is consistent enough to project 17.7-18.1% for FY2027. The midpoint of this range (17.9%) would resolve YES, but barely. The absolute dollar math is tight: $622.3M + 0.9% max = $628M. Historically SBC grew $12M in FY2026 — at that pace it hits $634M, above threshold. But the FY2025 data point ($610M → $622M, +$12M) may reflect catch-up grants after the very flat FY2024→FY2025 period. A reasonable base rate, weighting both the percentage trend and absolute dollar dynamics: 55% YES.

Management guidance analysis: CFO Grayson made an unusually direct commitment — 'I expect it to decline again into fiscal 27.' CFOs rarely make such explicit forward statements about SBC trajectory unless they have strong internal visibility and control levers. The four structural levers cited (head count in lower-cost locations, fewer executive grants, PSU shift, cash substitution) are all operationally credible and within management's direct control. Unlike revenue growth (which depends on market conditions), SBC is largely a management choice. The $5.9M cushion is thin, but management knows the exact number they need to hit and has explicitly committed to it. The risk is that competitive pressures (AI talent, C-suite sales hires) force management to deviate from their stated intent. But CFO commitments of this specificity are typically met — they know investors will track this metric. Guidance-based probability: 65%.

Management has committed to SBC decline and has the tools to deliver it. However, the margin is extremely thin. Revenue outperformance (which would increase the denominator) helps — if revenue comes in at $3,520M instead of $3,490M guided, the threshold rises to $634M, giving more room. Conversely, revenue at the low end ($3,484M) means SBC must stay below $627M. The guidance beat pattern is relevant: if DocuSign beats revenue guidance as usual, the denominator grows and makes 18% easier to achieve. CFO's commitment combined with likely revenue outperformance creates a reasonable path to YES. But new executive hiring for C-suite sales and AI could create $10-15M in incremental equity grants that management may not have fully anticipated. Guidance-weighted probability: 62%.

CFO commitment analysis: The statement 'I expect it to decline again' in response to a direct analyst question (Patrick Walravens, Citizens JMP) carries significant weight. CFOs who make public forward guidance on specific metrics tend to manage toward those outcomes. However, 'decline' is ambiguous — decline from 19.3% could mean 19.0% (YES at 18% threshold? NO). The CFO said decline, not 'reach below 18%.' The commitment is to directional improvement, not to the specific threshold. Management may achieve 18.5% SBC/revenue and technically deliver on the 'decline again' commitment while still resolving NO on this market. This nuance slightly tempers the guidance signal. Probability: 60%.

Cross-signal analysis: Several signals create tension. BULLISH signals: (1) Head count grew only 3% in FY2026 with hiring in lower-cost geographies — directly reduces SBC per employee. (2) $158M buyback in Q1 FY2027 shows capital allocation discipline. (3) The predecessor market resolved YES (SBC below 20%), showing management follows through on SBC discipline. BEARISH signals: (1) R&D grew 13% YoY — the fastest-growing OpEx line, and R&D compensation is equity-heavy. (2) New C-suite sales motion requires senior executive hires with large equity packages. (3) Tax withholding on RSUs grew to $269.7M — implies growing gross equity compensation. (4) New board member from a16z background may influence toward equity-heavy comp. Net cross-signal: slightly positive but with material uncertainty from R&D and executive hiring. 60% YES.

Cross-signal analysis with emphasis on risks: The biggest cross-signal risk is the tension between SBC discipline and the company's stated strategic priorities. DocuSign is simultaneously (1) launching consumption-based pricing requiring specialized engineering, (2) building a C-suite sales motion requiring premium executive talent, (3) investing in IAM platform expansion, and (4) competing for AI talent. Each of these initiatives puts upward pressure on equity compensation. Management may face a choice between hitting the SBC target and adequately staffing these strategic priorities. In technology companies, the strategic imperative usually wins over the cost metric. The PSU shift helps (underperformers forfeit), but new grant levels for high-demand roles (AI, enterprise sales) could offset savings from lower-cost location hiring. The margin is thin enough that a single large executive hire could tip the outcome. 56% YES.

Cross-signal synthesis: The resolution date is April 30, 2027 — a full fiscal year away. This long time horizon introduces more uncertainty than a quarterly market. Over 12 months, multiple factors could push SBC either way: a major acquisition (likely equity-funded), executive departures/replacements (new grants), or accelerated hiring for new product lines. The PSU shift is the most structurally bullish factor — PSUs that don't vest reduce recognized SBC expense. DocuSign's mention of 'leaning more into cash compensation' is significant if followed through. Cross-referencing with the revenue market: if Q1 revenue beats (likely per our 81% estimate), that helps the denominator. If FY2027 total revenue comes in at $3,530M vs $3,490M guided, the SBC threshold rises to $636M, giving $13.7M of room instead of $5.9M. Revenue outperformance is the most likely path to YES. 58% probability.